BSEGodavari Drugs LtdMediumNeutral
Announced Mon, 29 Sept · 12:57 IST

Disclosure under Regulation 30 of SEBI LODR 2015 - Appointment of Ms. Shilpa Bung (DIN: 08257931) as a Non-Executive Independent Director of the company for a Period of 5 years and Appointment ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Godavari Drugs Ltd has informed the stock exchange about two key appointments approved at its AGM. Mrs. Shilpa Bung (DIN: 08257931) has been appointed as a Non-Executive Independent Director for a five-year term effective from 29 May 2025. She is a qualified Company Secretary and Law graduate with expertise in corporate governance and compliance. Additionally, M/s. VSS & Associates, a Hyderabad-based firm of Practicing Company Secretaries with over 15 years of experience, has been appointed as the Secretarial Auditor for five financial years from FY 2025-26 to FY 2029-30. The AGM concluded at 4:02 PM on 29 September 2025.

Likely market impact

These are routine governance appointments with no material impact on shareholders. Appointment of a qualified independent director and a reputed secretarial auditor signals continued focus on board independence and regulatory compliance, which is mildly positive for governance quality.